The First 90 Days After Ibogaine: A Recovery Integration Roadmap
Key Takeaways Aftercare planning is an important step to prepare before treatment begins. The question “What are my next steps?” should be answered before a patient arrives at the clinic, not after they land back
Read More
Ibogaine vs. Suboxone and Methadone Maintenance in Long-Term Recovery
Key Takeaways Buprenorphine with naloxone and methadone are maintenance medications. They work by keeping mu-opioid receptors occupied so withdrawal and cravings stay controlled, and both have a large evidence base behind them. Ibogaine is being
Read More
Benzodiazepine Addiction, Dependence, and Ibogaine Treatment
Key Takeaways Benzodiazepine addiction is different from physical dependence on the drug, which can occur even with prescribed use. Addiction involves loss of control, cravings, and continued use despite harm. Stopping benzodiazepines abruptly can trigger
Read More
Ibogaine Treatment and Nicotine Addiction: What We Know About Its Potential and Limitations
Key Takeaways Bottom line: current evidence does not establish ibogaine as a proven or reliable nicotine-cessation treatment in humans, and its safety and efficacy specifically for nicotine remains uncertain. Laboratory and animal studies suggest ibogaine
Read More
Ibogaine vs. Traditional Rehab: Why the Outcomes Are Different
Key Takeaways Ibogaine and traditional rehab take fundamentally different approaches to addiction recovery, with ibogaine focusing on neurological reset and traditional rehab emphasizing behavioral therapy and long-term management. Ibogaine may rapidly reduce withdrawal symptoms and
Read More
How to Prepare for Ibogaine Treatment: A Complete Pre-Treatment Guide
Key Takeaways A thorough medical evaluation comes first. Your clinic needs a complete picture of your health history, current medications, past substance use, and any existing cardiac, liver, kidney, or neurological conditions before determining whether ibogaine
Read More
What Is Noribogaine and Why Does It Matter for Long-Term Recovery?
Key Takeaways Noribogaine is the primary active metabolite of ibogaine, formed when the CYP2D6 enzyme in the cytochrome P450 group removes a methyl group from ibogaine during liver metabolism. Unlike ibogaine, noribogaine is not psychoactive.
Read More
Ibogaine Microdosing: What the Research Says So Far
Key Takeaways Ibogaine microdosing involves sub-perceptual doses aimed at supporting neuroplasticity and mood regulation without the intense psychoactive effects of a flood dose. While anecdotal reports and early animal studies suggest potential benefits for addiction
Read More
Ibogaine vs Ketamine Therapy: Discover the Differences
Ibogaine and ketamine are two of the most discussed alternative therapies for addiction, depression, and trauma. Both can produce rapid shifts in neurochemistry and have helped individuals who found little relief in conventional treatments. Yet
Read More
Ibogaine Clinical Trials and FDA Status in 2026: What Patients Need to Know
Are there ongoing ibogaine clinical trials in 2026? Yes, but access remains extremely limited, and full FDA approval is years away. However, the landscape of ibogaine research is shifting rapidly, driven by new federal directives
Read More